Skip to main navigation

Learn More About Selective Chemoprotection

About Us
Our Science
Our Opportunity
Clinical Development
Scientific Resources
Investors & Media
Careers

Stop Accepting,
Start Protecting.

Connect LinkedIn

Investors & Media

Overview
Press Releases
Events & Presentations
Stock Info
- Stock Quote & Chart
- Analyst Coverage
Governance
Financial Info
- SEC Filings
- Annual Reports
Investor Info

IR Contact

IR Contact

Investor Contacts

Liz Melone

E-mail: lmelone@aileronrx.com

Alexander Lobo

Stern Investor Relations
E-mail: alex.lobo@sternir.com

Let's stop accepting chemotherapy-induced side effects and start protecting against them.

Learn More About Selective Chemoprotection

Connect LinkedIn

© Copyright 2023 Aileron. Privacy policy. Terms of Use.